Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 5 minute read Pharma Industry News Will Biogen’s $1bn bet on Vanqua Bio’s oral inflammation drug jumpstart its post-MS future? Biogen’s $1.06B Vanqua Bio licensing deal signals a strategic shift toward immunology. Explore the roadmap behind this bold preclinical move. byPallavi MadhirajuOctober 25, 2025